Several leading companies worldwide focus on the synthesis of complex pharmaceutical APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone Mesylate. These compounds present significant hurdles in process creation due to their chemical intricacy. The producers of these APIs often employ specialized methods and adhere to strict regulatory